Cargando…
Can we predict if patients with SLE will require more than one cycle of rituximab?
OBJECTIVE: To identify clinical and serological features that distinguish patients with SLE who require single as opposed to repeated rituximab (RTX) cycles. METHODS: All 175 SLE patients followed up at University College Hospital from 2000 onwards were retrospectively reviewed. They were divided in...
Autores principales: | Fernández González, Raquel, Abida, Rym, Gisca, Eugeniu, Duarte, Leila, Isenberg, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071578/ https://www.ncbi.nlm.nih.gov/pubmed/34240116 http://dx.doi.org/10.1093/rheumatology/keab527 |
Ejemplares similares
-
SLE - Rituximab in lupus
por: Eisenberg, Robert
Publicado: (2003) -
B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab
and implications for study design
por: Reddy, Venkat, et al.
Publicado: (2013) -
A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE
por: van Dam, Laura S, et al.
Publicado: (2020) -
Use of Rituximab in child with SLE and myocardial involvement
por: Balan, S, et al.
Publicado: (2008) -
SLE‐associated myelitis successfully treated by rituximab
por: Khabbazi, Alireza, et al.
Publicado: (2022)